You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
A social cost perspective in the wake of the Portuguese strategy for the fight against drugs
|
|---|---|
| Published in |
International Journal of Drug Policy, September 2014
|
| DOI | 10.1016/j.drugpo.2014.08.017 |
| Pubmed ID | |
| Authors |
Ricardo Gonçalves, Ana Lourenço, Sofia Nogueira da Silva |
| Abstract |
The Portuguese National Strategy for the Fight Against Drugs (NSFAD), approved in 1999, was explicitly grounded on the values of humanism and pragmatism and paved the way for the decriminalization of illicit drug use in Portugal in 2000. This paper presents an analysis of the social costs of illicit drug use in the wake of the strategy's approval. Taking into consideration health and non-health related costs, we find that that the social cost of drugs decreased by 12% in the five years following the NSFAD's approval and by a rather significant 18% in the eleven-year period following its approval. Whilst the reduction of legal system costs (possibly associated with the decriminalization of drug consumption) is clearly one of the main explanatory factors, it is not the only one. In particular, the rather significant reduction of health-related costs has also played an important role. |
X Demographics
The data shown below were collected from the profiles of 94 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 19 | 20% |
| United Kingdom | 15 | 16% |
| Puerto Rico | 5 | 5% |
| Canada | 3 | 3% |
| Australia | 2 | 2% |
| Sweden | 1 | 1% |
| Colombia | 1 | 1% |
| Mexico | 1 | 1% |
| Ireland | 1 | 1% |
| Other | 5 | 5% |
| Unknown | 41 | 44% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 82 | 87% |
| Scientists | 6 | 6% |
| Science communicators (journalists, bloggers, editors) | 3 | 3% |
| Practitioners (doctors, other healthcare professionals) | 3 | 3% |
Mendeley readers
The data shown below were compiled from readership statistics for 168 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | <1% |
| Unknown | 167 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 37 | 22% |
| Student > Master | 29 | 17% |
| Researcher | 12 | 7% |
| Other | 8 | 5% |
| Professor | 8 | 5% |
| Other | 30 | 18% |
| Unknown | 44 | 26% |
| Readers by discipline | Count | As % |
|---|---|---|
| Social Sciences | 32 | 19% |
| Medicine and Dentistry | 28 | 17% |
| Psychology | 15 | 9% |
| Nursing and Health Professions | 7 | 4% |
| Economics, Econometrics and Finance | 5 | 3% |
| Other | 32 | 19% |
| Unknown | 49 | 29% |
Attention Score in Context
This research output has an Altmetric Attention Score of 124. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 October 2023.
All research outputs
#341,224
of 25,837,817 outputs
Outputs from International Journal of Drug Policy
#99
of 3,080 outputs
Outputs of similar age
#2,994
of 251,635 outputs
Outputs of similar age from International Journal of Drug Policy
#3
of 37 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,080 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 24.7. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 251,635 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 37 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 91% of its contemporaries.